Triheptanoin: Phase 11A Clinical Trial
PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Edit
Updated: 05/17/2019
Pipeline Type
Dietary Supplements
Phase Of Development
Phase 2
Sponsors and Collaborators
The University of Queensland, Australia, Epilepsy Therapy Project
Mechanism of Action
Mechanism Description
a triglyceride oil containing three odd-carbon chain-length fatty acids (i.e., a triglyceride of 7-carbon heptanoic acid).
Populations Tested In
Drug resistant seizures
(12 yr and older)
Other Resources
Special FDA Designation
Nonprofit or Government Support
N/A
Nonprofit or Government Support Description
N/A
Previous Presentations
Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
N/A
Location of Clinical Trials
Victoria, Australia
Clinical Trial link